Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review
Nirmatrelvir/Ritonavir is an oral treatment for mild to moderate COVID-19 cases with a high risk for a severe course of the disease. For this paper, a comprehensive literature review was performed, leading to a summary of currently available data on Nirmatrelvir/Ritonavir’s ability to reduce the ris...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2024-01-01
|
| Colecção: | Advances in Respiratory Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2543-6031/92/1/9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|